Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1296067

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1296067

Global Next Generation Sequencing Market 2023-2027

PUBLISHED:
PAGES: 171 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The next generation sequencing market is forecasted to grow by USD 3409.76 mn during 2022-2027, accelerating at a CAGR of 12.45% during the forecast period. The report on the next generation sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased utilization of NGS methods, growing demand for early diagnosis of genetic disorders, and availability of wide range of NGS products.

Technavio's next generation sequencing market is segmented as below:

By End-user

  • Academic research
  • Clinical research
  • Pharma & biotech companies
  • Others

By Product

  • Consumables
  • Equipment

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advances in NGS techniques as one of the prime reasons driving the next generation sequencing market growth during the next few years. Also, reduced costs of gene sequencing and developments in bioinformatics and cloud-based software programs will lead to sizable demand in the market.

The report on the next generation sequencing market covers the following areas:

  • Next generation sequencing market sizing
  • Next generation sequencing market forecast
  • Next generation sequencing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading next generation sequencing market vendors that include 10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the next generation sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR71618

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global next generation sequencing market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global next generation sequencing market 2017 - 2021 ($ million)
  • 4.2 End-user Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • 4.3 Product Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

  • 6.1 Market segments
  • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
  • 6.2 Comparison by End-user
  • Exhibit 32: Chart on Comparison by End-user
  • Exhibit 33: Data Table on Comparison by End-user
  • 6.3 Academic research - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
  • 6.4 Clinical research - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
  • 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027
  • Exhibit 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • 6.6 Others - Market size and forecast 2022-2027
  • Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.7 Market opportunity by End-user
  • Exhibit 50: Market opportunity by End-user ($ million)
  • Exhibit 51: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

  • 7.1 Market segments
  • Exhibit 52: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 53: Data Table on Product - Market share 2022-2027 (%)
  • 7.2 Comparison by Product
  • Exhibit 54: Chart on Comparison by Product
  • Exhibit 55: Data Table on Comparison by Product
  • 7.3 Consumables - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
  • 7.4 Equipment - Market size and forecast 2022-2027
  • Exhibit 60: Chart on Equipment - Market size and forecast 2022-2027 ($ million)
  • Exhibit 61: Data Table on Equipment - Market size and forecast 2022-2027 ($ million)
  • Exhibit 62: Chart on Equipment - Year-over-year growth 2022-2027 (%)
  • Exhibit 63: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
  • 7.5 Market opportunity by Product
  • Exhibit 64: Market opportunity by Product ($ million)
  • Exhibit 65: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 69: Chart on Geographic comparison
  • Exhibit 70: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
  • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 Canada - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.10 China - Market size and forecast 2022-2027
  • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.11 UK - Market size and forecast 2022-2027
  • Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity By Geographical Landscape
  • Exhibit 107: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 111: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 112: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 113: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 114: Matrix on vendor position and classification
  • 12.3 10X Genomics Inc.
  • Exhibit 115: 10X Genomics Inc. - Overview
  • Exhibit 116: 10X Genomics Inc. - Product / Service
  • Exhibit 117: 10X Genomics Inc. - Key offerings
  • 12.4 Azenta Inc.
  • Exhibit 118: Azenta Inc. - Overview
  • Exhibit 119: Azenta Inc. - Business segments
  • Exhibit 120: Azenta Inc. - Key offerings
  • Exhibit 121: Azenta Inc. - Segment focus
  • 12.5 BGI Genomics Co. Ltd.
  • Exhibit 122: BGI Genomics Co. Ltd. - Overview
  • Exhibit 123: BGI Genomics Co. Ltd. - Product / Service
  • Exhibit 124: BGI Genomics Co. Ltd. - Key offerings
  • 12.6 Bio Rad Laboratories Inc.
  • Exhibit 125: Bio Rad Laboratories Inc. - Overview
  • Exhibit 126: Bio Rad Laboratories Inc. - Business segments
  • Exhibit 127: Bio Rad Laboratories Inc. - Key news
  • Exhibit 128: Bio Rad Laboratories Inc. - Key offerings
  • Exhibit 129: Bio Rad Laboratories Inc. - Segment focus
  • 12.7 Eurofins Scientific SE
  • Exhibit 130: Eurofins Scientific SE - Overview
  • Exhibit 131: Eurofins Scientific SE - Business segments
  • Exhibit 132: Eurofins Scientific SE - Key news
  • Exhibit 133: Eurofins Scientific SE - Key offerings
  • Exhibit 134: Eurofins Scientific SE - Segment focus
  • 12.8 F. Hoffmann La Roche Ltd.
  • Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.9 Illumina Inc.
  • Exhibit 140: Illumina Inc. - Overview
  • Exhibit 141: Illumina Inc. - Business segments
  • Exhibit 142: Illumina Inc. - Key news
  • Exhibit 143: Illumina Inc. - Key offerings
  • Exhibit 144: Illumina Inc. - Segment focus
  • 12.10 Konica Minolta Inc.
  • Exhibit 145: Konica Minolta Inc. - Overview
  • Exhibit 146: Konica Minolta Inc. - Business segments
  • Exhibit 147: Konica Minolta Inc. - Key news
  • Exhibit 148: Konica Minolta Inc. - Key offerings
  • Exhibit 149: Konica Minolta Inc. - Segment focus
  • 12.11 Laboratory Corp. of America Holdings
  • Exhibit 150: Laboratory Corp. of America Holdings - Overview
  • Exhibit 151: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 152: Laboratory Corp. of America Holdings - Key news
  • Exhibit 153: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 154: Laboratory Corp. of America Holdings - Segment focus
  • 12.12 Merck KGaA
  • Exhibit 155: Merck KGaA - Overview
  • Exhibit 156: Merck KGaA - Business segments
  • Exhibit 157: Merck KGaA - Key news
  • Exhibit 158: Merck KGaA - Key offerings
  • Exhibit 159: Merck KGaA - Segment focus
  • 12.13 Perkin Elmer Inc.
  • Exhibit 160: Perkin Elmer Inc. - Overview
  • Exhibit 161: Perkin Elmer Inc. - Business segments
  • Exhibit 162: Perkin Elmer Inc. - Key news
  • Exhibit 163: Perkin Elmer Inc. - Key offerings
  • Exhibit 164: Perkin Elmer Inc. - Segment focus
  • 12.14 QIAGEN NV
  • Exhibit 165: QIAGEN NV - Overview
  • Exhibit 166: QIAGEN NV - Product / Service
  • Exhibit 167: QIAGEN NV - Key news
  • Exhibit 168: QIAGEN NV - Key offerings
  • 12.15 Standard BioTools Inc.
  • Exhibit 169: Standard BioTools Inc. - Overview
  • Exhibit 170: Standard BioTools Inc. - Product / Service
  • Exhibit 171: Standard BioTools Inc. - Key news
  • Exhibit 172: Standard BioTools Inc. - Key offerings
  • 12.16 Takara Bio Inc.
  • Exhibit 173: Takara Bio Inc. - Overview
  • Exhibit 174: Takara Bio Inc. - Business segments
  • Exhibit 175: Takara Bio Inc. - Key offerings
  • Exhibit 176: Takara Bio Inc. - Segment focus
  • 12.17 Thermo Fisher Scientific Inc.
  • Exhibit 177: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 178: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 179: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 180: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 181: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 182: Inclusions checklist
  • Exhibit 183: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 184: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 185: Research methodology
  • Exhibit 186: Validation techniques employed for market sizing
  • Exhibit 187: Information sources
  • 13.5 List of abbreviations
  • Exhibit 188: List of abbreviations
Product Code: IRTNTR71618

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on global next generation sequencing market 2017 - 2021 ($ million)
  • Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
  • Exhibits20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on End-user - Market share 2022-2027 (%)
  • Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by End-user
  • Exhibits33: Data Table on Comparison by End-user
  • Exhibits34: Chart on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibits35: Data Table on Academic research - Market size and forecast 2022-2027 ($ million)
  • Exhibits36: Chart on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Academic research - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibits39: Data Table on Clinical research - Market size and forecast 2022-2027 ($ million)
  • Exhibits40: Chart on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Clinical research - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2022-2027 ($ million)
  • Exhibits44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • Exhibits45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2022-2027 (%)
  • Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
  • Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Market opportunity by End-user ($ million)
  • Exhibits51: Data Table on Market opportunity by End-user ($ million)
  • Exhibits52: Chart on Product - Market share 2022-2027 (%)
  • Exhibits53: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits54: Chart on Comparison by Product
  • Exhibits55: Data Table on Comparison by Product
  • Exhibits56: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibits57: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
  • Exhibits58: Chart on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
  • Exhibits60: Chart on Equipment - Market size and forecast 2022-2027 ($ million)
  • Exhibits61: Data Table on Equipment - Market size and forecast 2022-2027 ($ million)
  • Exhibits62: Chart on Equipment - Year-over-year growth 2022-2027 (%)
  • Exhibits63: Data Table on Equipment - Year-over-year growth 2022-2027 (%)
  • Exhibits64: Market opportunity by Product ($ million)
  • Exhibits65: Data Table on Market opportunity by Product ($ million)
  • Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits69: Chart on Geographic comparison
  • Exhibits70: Data Table on Geographic comparison
  • Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits103: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibits105: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits106: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits107: Market opportunity By Geographical Landscape ($ million)
  • Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits109: Impact of drivers and challenges in 2022 and 2027
  • Exhibits110: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits111: Overview on factors of disruption
  • Exhibits112: Impact of key risks on business
  • Exhibits113: Vendors covered
  • Exhibits114: Matrix on vendor position and classification
  • Exhibits115: 10X Genomics Inc. - Overview
  • Exhibits116: 10X Genomics Inc. - Product / Service
  • Exhibits117: 10X Genomics Inc. - Key offerings
  • Exhibits118: Azenta Inc. - Overview
  • Exhibits119: Azenta Inc. - Business segments
  • Exhibits120: Azenta Inc. - Key offerings
  • Exhibits121: Azenta Inc. - Segment focus
  • Exhibits122: BGI Genomics Co. Ltd. - Overview
  • Exhibits123: BGI Genomics Co. Ltd. - Product / Service
  • Exhibits124: BGI Genomics Co. Ltd. - Key offerings
  • Exhibits125: Bio Rad Laboratories Inc. - Overview
  • Exhibits126: Bio Rad Laboratories Inc. - Business segments
  • Exhibits127: Bio Rad Laboratories Inc. - Key news
  • Exhibits128: Bio Rad Laboratories Inc. - Key offerings
  • Exhibits129: Bio Rad Laboratories Inc. - Segment focus
  • Exhibits130: Eurofins Scientific SE - Overview
  • Exhibits131: Eurofins Scientific SE - Business segments
  • Exhibits132: Eurofins Scientific SE - Key news
  • Exhibits133: Eurofins Scientific SE - Key offerings
  • Exhibits134: Eurofins Scientific SE - Segment focus
  • Exhibits135: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits136: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits137: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits138: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits139: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits140: Illumina Inc. - Overview
  • Exhibits141: Illumina Inc. - Business segments
  • Exhibits142: Illumina Inc. - Key news
  • Exhibits143: Illumina Inc. - Key offerings
  • Exhibits144: Illumina Inc. - Segment focus
  • Exhibits145: Konica Minolta Inc. - Overview
  • Exhibits146: Konica Minolta Inc. - Business segments
  • Exhibits147: Konica Minolta Inc. - Key news
  • Exhibits148: Konica Minolta Inc. - Key offerings
  • Exhibits149: Konica Minolta Inc. - Segment focus
  • Exhibits150: Laboratory Corp. of America Holdings - Overview
  • Exhibits151: Laboratory Corp. of America Holdings - Business segments
  • Exhibits152: Laboratory Corp. of America Holdings - Key news
  • Exhibits153: Laboratory Corp. of America Holdings - Key offerings
  • Exhibits154: Laboratory Corp. of America Holdings - Segment focus
  • Exhibits155: Merck KGaA - Overview
  • Exhibits156: Merck KGaA - Business segments
  • Exhibits157: Merck KGaA - Key news
  • Exhibits158: Merck KGaA - Key offerings
  • Exhibits159: Merck KGaA - Segment focus
  • Exhibits160: Perkin Elmer Inc. - Overview
  • Exhibits161: Perkin Elmer Inc. - Business segments
  • Exhibits162: Perkin Elmer Inc. - Key news
  • Exhibits163: Perkin Elmer Inc. - Key offerings
  • Exhibits164: Perkin Elmer Inc. - Segment focus
  • Exhibits165: QIAGEN NV - Overview
  • Exhibits166: QIAGEN NV - Product / Service
  • Exhibits167: QIAGEN NV - Key news
  • Exhibits168: QIAGEN NV - Key offerings
  • Exhibits169: Standard BioTools Inc. - Overview
  • Exhibits170: Standard BioTools Inc. - Product / Service
  • Exhibits171: Standard BioTools Inc. - Key news
  • Exhibits172: Standard BioTools Inc. - Key offerings
  • Exhibits173: Takara Bio Inc. - Overview
  • Exhibits174: Takara Bio Inc. - Business segments
  • Exhibits175: Takara Bio Inc. - Key offerings
  • Exhibits176: Takara Bio Inc. - Segment focus
  • Exhibits177: Thermo Fisher Scientific Inc. - Overview
  • Exhibits178: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits179: Thermo Fisher Scientific Inc. - Key news
  • Exhibits180: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits181: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits182: Inclusions checklist
  • Exhibits183: Exclusions checklist
  • Exhibits184: Currency conversion rates for US$
  • Exhibits185: Research methodology
  • Exhibits186: Validation techniques employed for market sizing
  • Exhibits187: Information sources
  • Exhibits188: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!